Edition:
United States

Becton Dickinson and Co (BDX)

BDX on New York Consolidated

249.98USD
24 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$249.98
Open
--
Day's High
--
Day's Low
--
Volume
100
Avg. Vol
1,314,297
52-wk High
$265.87
52-wk Low
$208.62

About

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $67,260.46
Shares Outstanding(Mil.): 269.06
Dividend: 0.77
Yield (%): 1.23

Financials

  BDX Industry Sector
P/E (TTM): 52.10 32.72 37.40
EPS (TTM): 4.80 -- --
ROI: 3.06 13.43 12.12
ROE: 6.18 67.33 17.02

Becton Dickinson unit settles U.S. probe over unapproved medical devices

Becton Dickinson subsidiary CareFusion has agreed to pay $3.3 million to resolve claims that it bought and sold medical devices that did not have approval by the Food and Drug Administration, the Justice Department said on Monday.

May 13 2019

Earnings vs. Estimates